Mainz Biomed adds Eurofins GeLaMed to its lab partners list
- Mainz Biomed NV (NASDAQ:MYNZ) has added Eurofins GeLaMed to its network of lab partners offering PCR test kit processing of ColoAlert, its flagship product that is a highly efficacious and easy to use at-home screening test for colorectal cancer.
- Under the terms of the agreement, Eurofins GeLaMed will offer ColoAlert at its testing sites and Mainz Biomed will assist with physician and patient education programs as part of the product launch, highlighting the importance of early screening for the detection and prevention of CRC.